CLINICAL_TRIALS
trial_result
· 2016-04-15
Clinical Trial Update: Sitagliptin Cardiovascular Outcomes Study (MK-0431-082) [Phase 3]
Summary
Phase 3 results update for sitagliptin cardiovascular outcomes study (MK-0431-082) in type 2 diabetes mellitus; trial completed with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2016-04-15